Loading...
NPI 1487221404 · Saint Louis, MO · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Eye Surgical Services LLC is a ambulatory surgical clinic/center provider located in Saint Louis, Missouri. This profile covers 25 Medicare and 3 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Eye Surgical Services LLC |
| Address | 10296 Big Bend Rd Ste 100 |
| City | Saint Louis |
| State | MO |
| ZIP | 63122 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | June 8, 2021 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.2M |
| Medicaid | $31.4K |
EYE SURGICAL SERVICES LLC operates as an Ambulatory Surgical Clinic/Center with a procedure mix concentrated in ophthalmic surgery: the Medicare top codes and descriptions show routine extracapsular cataract extraction with lens insertion (66984), glaucoma-related limbal incision procedures (65820), and YAG capsulotomy (66821), indicating the practice is structured around outpatient cataract and anterior-segment surgical services rather than primary-care or broad multispecialty care. The code mix also includes vitreoretinal procedures and eyelid reconstructive codes, consistent with a surgical specialty ASC handling both cataract workflows and a range of ancillary ophthalmic surgeries.
Medicare revenue is highly concentrated: the provider reports $2.2M in total Medicare revenue and its precomputed top 3 Medicare codes account for 67.9% of that Medicare revenue. Within that concentration, 66984 alone represents $1.3M (57.7% of Medicare revenue) and is the dominant Medicare line item for this practice, reinforcing cataract surgery as the primary revenue driver.
On Medicaid the provider is effectively monolithic around the same primary service: total Medicaid revenue is $31.4K and the precomputed top 3 Medicaid codes account for 100.0% of Medicaid revenue. Code 66984 drives the vast majority of Medicaid billing at $29.1K (92.9% of Medicaid revenue) with the remaining Medicaid dollars coming from two supply/drug codes (J1097 and J2403), underscoring that cataract extractions dominate the small Medicaid footprint.
Payer mix is heavily Medicare-weighted: with $2.2M from Medicare versus $31.4K from Medicaid, the entity is effectively Medicare-dominated in scale and not a significant Medicaid provider. This skew suggests contracting, operational capacity, and referral patterns are primarily tuned to Medicare populations and reimbursement.
Competitive standing is mixed across codes: the provider’s Medicare 66984 performance ranks #1365 of 15965 nationally (around the 91st percentile), which places it well above most individual providers in absolute volume for cataract extraction but still within a large national peer set described as typical/unremarkable volume for the code. Meanwhile 66821 appears as a relative specialty signal — it is described as notably above typical national volume and ranks in the 98th percentile nationally, indicating stronger-than-typical use of YAG capsulotomy compared with peers and suggesting a higher proportion of postoperative or secondary-cataract care.
There are localized differences between Medicare and Medicaid competitive metrics: for Medicaid, 66984 ranks #10 of 61 in-state (83rd percentile), a solid in-state placement but not dominant; J1097 and J2403 are reported with small Medicaid revenue shares and atypical rank notes (J1097 listed as #1 of 1 in-state with no state peer comparison available, and J2403 as #1 of 2 in-state at the 100th percentile), reflecting a very small Medicaid sample dominated by the cataract code and limited state peer activity for the listed supplies.
Statistical outliers and specialty signals are present beyond the cataract core: Medicare code 66821 is flagged as notably above typical national volume (98th percentile), and eyelid/ocular surface repair codes such as 67917 also show elevated national placement (94th percentile), while certain services like full-thickness corneal transplant (65756) appear low relative to national peers (10th percentile). These contrasts indicate the ASC’s emphasis on cataract and secondary-cataract procedures with selective higher-than-typical volumes in some eyelid and posterior-segment interventions rather than broad high-volume corneal transplant activity.
Tenure and operational maturity are limited but established: the NPI was enumerated on 2021-06-08 (~5 years ago), indicating the practice has been billing Medicare/Medicaid for multiple years but is not a long-standing multi-decade institution; this aligns with an ambulatory surgical center that has built a concentrated cataract surgery volume in a relatively short operating window.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
25 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 1,620 | $810 | $1.3M |
| 65820 | The provider incises the limbus to improve drainage of aqueous humor in the eye. This procedure is typically performed on children, usually to treat congenital glaucoma. | 80 | $1,490 | $120.3K |
| 66821 | The provider removes the haziness from the capsule of the eye using a laser for a patient with a secondary membranous cataract. | 530 | $210 | $108.8K |
| 66982 | The provider inserts an intraocular lens prosthesis after extracapsular cataract extraction using complex techniques and devices. He may perform this by means of an iris expansion device, providing… | 110 | $830 | $93.7K |
| 66991 | The provider inserts an intraocular lens prosthesis during the same session as extracapsular cataract extraction. The provider also inserts one or more anterior segment aqueous drainage devices in… | 30 | $2,500 | $85.1K |
| 15823 | In this procedure, the provider surgically trims excessive skin that weighs down the upper eyelid, typically to improve the cosmetic appearance of the face and due to the interference of the tissue… | 130 | $500 | $61.9K |
| 67042 | In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina… | 40 | $1,500 | $59.9K |
| 67036 | The provider removes vitreous fluid from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana. | 30 | $1,440 | $44.6K |
| J1097 | phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 550 | $80 | $43.1K |
| 66174 | The provider expands the aqueous outflow (drainage) canal of the eye to help relieve pressure in the eye. The procedure does not include leaving a device or stent in place. | 40 | $990 | $38.4K |
Showing 1–10 of 25
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
25 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J1097 | 7 | 10 | 1,360 | $80 | $106.4K |
| 66984 | 5 | 420 | 50 | $390 | $74K |
| 66991 | 15 | 30 | 30 | $1,230 | $55.5K |
| J2403 | 8 | 10 | 82,800 | $1 | $55K |
| 68326 | 1 | 10 | 40 | $1,000 | $38.1K |
| 65820 | 4 | 40 | 30 | $790 | $29.1K |
| 15823 | 4 | 40 | 40 | $530 | $28.6K |
| 67042 | 4 | 30 | 20 | $1,070 | $26.8K |
| 67036 | 6 | 20 | 20 | $980 | $25.5K |
| 66982 | 2 | 80 | 20 | $610 | $22.5K |
Showing 1–10 of 25
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 320 | $90 | $29.1K |
| J1097 | phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 100 | $10 | $1.3K |
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 70 | $10 | $920 |
How this provider's Medicaid billing volume and revenue compare to other Missouri providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Missouri median
3 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 10 | 60 | 80 | $280 | $53.5K |
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 1 | 10 | 50 | $50 | $2.8K |
| J1097 | phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 1 | 10 | 100 | $10 | $1.3K |
Other providers in the same ZIP code as Eye Surgical Services LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.